Speaking at the Joint Committee on Health this morning (13th March) Cancer Trials Ireland highlighted that due to funding cut backs of €750,000 per year it had has not been able to open clinically important cancer trials in Ireland that could improve the outcomes for people with cancer. Eibhlín Mulroe, CEO, Cancer Trials Ireland, said […]
Read the latest project news in our Winter 2019 COLOSSUS newsletter. Get an update on the COLOSSUS translational trial and read the dissemination highlights too. In this edition, our ‘Partner in the Spotlight” is Cancer Trials Ireland. Download the newsletter here.
Congratulations to Dr Mihai and the Clinical Trials Research Unit at Beacon Hospital on their input to the international Oligorecurrent Stereotactic trial which indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation […]
We’re delighted to be working with colleagues around the world and playing our part in discovering better diagnostics and treatments.
Our Spring DSSG Meeting will be held on Friday, 22nd March @ Cancer Trials Ireland, Innovation House, Glasnevin Dublin 11 Time: 8am – 5pm (Agenda to follow) For more information: email@example.com Telephone: (01) 66 77 211
Thanks to the IPU Review for featuring Cancer Trials Ireland in its magazine circulated to all community pharmacists. IPU Dec 2018 article
We are delighted to announce that Jacinta Marron has been appointed to the newly created post of Head of Biometrics at Cancer Trials Ireland. As Head of Biometrics, Jacinta will lead the Biometrics unit of Data Management and Statistics in collaboration with Group Statistician, Imelda Parker. Jacinta joined Cancer Trials Ireland in 2015 and has […]
Here are full details of the 7 posters & abstracts which were presented at ESMO 2018 Congress involving Cancer Trials Ireland Members. The congress attracted 28,000 attendees. DETAILS HERE ESMO 2018
The JAVELIN Head & Neck 100 trial is the first of its kind to open in Ireland. It increases treatment opportunities for some Irish patients. It is a Phase III double-blind randomised controlled trial (RCT) studying the effect of avelumab, versus placebo, in combination with standard of care CRT in the frontline treatment of patients […]
Up to 268 patients will take part in the TRI LARC trial which is investigating how to reduce side effects for patients undergoing radiotherapy (RT) treatment for rectal cancer. The trial is sponsored by Cancer Trials Ireland and will open in six Irish radiation oncology departments. The trial is so far open in the St Luke’s Radiation […]